Black Diamond Therapeutics BDTX

$ 2.33 -4.32%

Quarterly report 2024-Q3
added 11-05-2024

Black Diamond Therapeutics Financial Statements 2011-2024 | BDTX

Annual Financial Statements Black Diamond Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	166 M	54.5 M	193 M	890 M	1.29 B	-	-	-	-	-	-	-	-
Shares	44 M	36.3 M	36.2 M	35.9 M	32.6 M	-	-	-	-	-	-	-	-
Historical Prices	3.78	1.5	5.33	32	-	-	-	-	-	-	-	-	-
Net Income	-82.4 M	-91.2 M	-126 M	-67.3 M	-35.3 M	-8.93 M	-4.6 M	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-86.5 M	-92.8 M	-127 M	-69.6 M	-29.3 M	-8.9 M	-	-	-	-	-	-	-
Interest Expense	2.09 M	-354 K	-2.19 M	1 K	-	-16 K	-	-	-	-	-	-	-
EBITDA	-86 M	-92.3 M	-127 M	-67.2 M	-22.9 M	-8.87 M	-4.1 M	-	-	-	-	-	-
Operating Expenses	86.5 M	92.8 M	127 M	69.6 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	27.1 M	28.4 M	30 M	21.4 M	7.58 M	1.95 M	666 K	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Black Diamond Therapeutics

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	56.5 M	55.2 M	51.6 M	50.9 M	36.5 M	36.5 M	36.4 M	36.3 M	36.3 M	36.3 M	36.2 M	36.2 M	36.2 M	36.1 M	36.1 M	35.9 M	35.9 M	23.7 M	2.24 M	2.07 M	2.05 M	2.04 M	2.17 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-15.6 M	-19.9 M	-	-23 M	-19.2 M	-20.9 M	-	-21.7 M	-22.9 M	-25.5 M	-	-35.1 M	-34.4 M	-30.3 M	-22.6 M	-17.9 M	-14.6 M	-12.1 M	-9.88 M	-9.27 M	-12.3 M	-3.83 M	-3.07 M	-2.36 M	-1.91 M	-1.59 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-18.1 M	-22.1 M	-	-24 M	-20 M	-21.6 M	-	-22.1 M	-23.2 M	-25.7 M	-	-35.4 M	-34.7 M	-30.7 M	-23.2 M	-18.5 M	-15 M	-12.9 M	-10.3 M	-8.15 M	-7 M	-3.84 M	-3.05 M	-2.34 M	-1.91 M	-1.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	2.06 M	1.76 M	-	566 K	341 K	64 K	-	-92 K	-143 K	-234 K	-	-489 K	-584 K	-740 K	-	-	1 K	-10 K	-	-	-	2 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-21.4 M	-	-21.7 M	-22.9 M	-25.6 M	-	-35.3 M	-34.7 M	-30.7 M	-23.2 M	-18.4 M	-15 M	-12.9 M	-10.3 M	-8.11 M	-6.97 M	-3.83 M	-3.05 M	-2.34 M	-1.91 M	-1.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	18.1 M	22.1 M	-	24 M	20 M	21.6 M	-	22.1 M	23.2 M	25.7 M	-	35.4 M	34.7 M	30.7 M	23.2 M	18.5 M	15 M	12.9 M	10.3 M	8.15 M	7 M	3.84 M	3.05 M	2.34 M	1.91 M	1.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	5.22 M	9.57 M	-	7.86 M	6.88 M	6.81 M	-	6.28 M	6.98 M	7.89 M	-	7.74 M	8 M	7.89 M	-	5.55 M	4.86 M	5.52 M	-	2.51 M	1.35 M	828 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency